At a glance
- Originator Kyowa Hakko
- Class Analgesics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 26 May 2001 No-Development-Reported for Pain in Japan (Unknown route)
- 21 Sep 1998 Preclinical development for Pain in Japan (Unknown route)